Clinical trials: Radiation Dermatitis Acute
Radiodermatitis; Acute, Radiotherapy Side Effect
The Use of Photobiomodulation in the Management of Radiodermatitis in Head and Neck Cancer Patients
It is estimated that there will be 670,000 new cases of cancer worldwide in 2020-2022 and it is known that the most commonly instituted treatments in cancer are chemotherapy, radiotherapy and surgery.
- Conditions
- Radiodermatitis; Acute, Radiotherapy Side Effect, Head and Neck Cancer
- Trial name
- NCT05557825
- Testing
- Photobiomodulation Therapy
- Where
- Brazil
- Volunteers
- 3 people
- Sponsor
- University of Nove de Julho
Acute Radiation Dermatitis
Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis
Acute radiation dermatitis (ARD) is almost universally experienced by patients with cancer during or after radiation therapy. This condition potentially leads to detrimental clinical outcomes as it adversely affects adherence to…
- Trial name
- NCT05079763
- Testing
- Bacterial cellulose-monolaurin hydrogel
- Where
- Philippines
- Volunteers
- 54 people
- Sponsor
- University of the Philippines
Radiodermatitis, Radiation Toxicity
A Novel Skin Barrier Protectant for Acute Radiodermatitis
Acute radiodermatitis (ARD) is a distressing and painful skin reaction that occurs in 95% of the patients undergoing radiotherapy (RT).
- Conditions
- Radiodermatitis, Radiation Toxicity, Radiation Dermatitis, Skin Diseases
- Trial name
- CASP-ORL (NCT04593914)
- Testing
- Cavilon Advanced Skin Protectant
- Where
- 2 sites in Belgium
- Sponsor
- Jessa Hospital
Radiodermatitis; Acute
Retrospective Observational Study on the Use of Advanced Bacterial-binding Dressings (DACC-coated Hydrogel Dressings) in Radiodermatitis
the study aimed to evaluate the clinical effectiveness, safety and tolerability of a DACC-coated hydrogel advanced dressing for the treatment of radiodermatitis in patients undergoing radiotherapy for breast cancer.
- Trial name
- RadioDACC (NCT07332754)
- Where
- Italy
- Volunteers
- 18 people
- Sponsor
- I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Early Radiation Dermatitis
Mometasone Furoate Cream Reduces Acute Radiation Dermatitis in Head and Neck Squamous Cell Carcinomas' Patients
Radiation dermatitis is an acute effect of radiation therapy,Especially in the neck skin of head and neck squamous cell carcinomas' patients.The investigators wanted to confirm the benefit of mometasone furoate (MF) in preventing…
- Trial name
- NCT02495064
- Testing
- Mometasone Furoate Cream
- Where
- China
- Volunteers
- 160 people
- Sponsor
- Yao Liao
Radiodermatitis, Injury, Radiation
Study Using Spray Skin Protector Versus Conventional Treatment to Prevent Acute Radiodermatitis.
This is a randomized, open-label, single-institution trial designed to evaluate the effectiveness of a spray skin protector in preventing moist desquamation caused by radiotherapy treatment.
- Trial name
- NCT04067310
- Testing
- Spray skin protector, moisturizer Dnativ Revita derm
- Where
- Brazil
- Volunteers
- 72 people
- Sponsor
- Instituto Nacional de Cancer, Brazil
Radiation Dermatitis, Radiation Dermatitis Acute
Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer
The aim of the present randomized double-blinded placebo-controlled clinical trial is to investigate if melatonin can protect against acute radiation dermatitis in patients with early breast cancer receiving radiation therapy…
- Conditions
- Radiation Dermatitis, Radiation Dermatitis Acute, Breast Cancer
- Trial name
- MELADERM (NCT03716583)
- Testing
- Melatonin, Dimethyl Sulfoxide
- Where
- Denmark
- Volunteers
- 48 people
- Sponsor
- Dennis Bregner Zetner
Radio Dermatitis, Polarized Light
Polarized Light Therapy for Radiation Dermatitis in Breast Cancer
This assessor-blinded randomized controlled trial aims to evaluate the efficacy of polarized polychromatic non-coherent light therapy as an adjunct to standard skin care in reducing acute radiation dermatitis in women with breast…
- Conditions
- Radio Dermatitis, Polarized Light, Breast Cancer Survivors
- Trial name
- PLARD-BREAST (NCT07600957)
- Testing
- Polarized Polychromatic Light Therapy, Standard Skin Care
- Where
- Egypt
- Volunteers
- 60 people
- Sponsor
- Beni-Suef University
Breast Cancer, Radiation Dermatitis
Prospective Assessment of Acute Skin Toxicities in Breast Cancer Patients Undergoing Retreatment with 40 Gy in 15 Fractions Radiation Therapy
The most common cancer affecting Canadian women is breast cancer, with an estimated 1 in 8 women expected to be diagnosed with breast cancer during their lifetime.
- Trial name
- NCT06729814
- Where
- Canada
- Volunteers
- 30 people
- Sponsor
- Sunnybrook Health Sciences Centre
Radiation Dermatitis Acute
Acute Radiation Dermatitis After Adjuvant Radiotherapy for Breast Cancer Patients With the Use of Silver-Plated Technology
Patients who are eligible to receive adjuvant whole breast radiotherapy with or without regional nodal irradiation as part of their care will be included in this study.
- Trial name
- NCT06831084
- Testing
- Silver plated technology (SPT) dressing
- Where
- United States
- Volunteers
- 17 people
- Sponsor
- Parul Barry